PEGylation
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
187
NCT03023540
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Phase: Phase 3
Role: Collaborator
Start: Mar 7, 2017
Completion: Dec 31, 2024
Loading map...